In a nutshell This study investigated the effectiveness of vibegron (RVT-901) in the treatment of overactive bladder (OAB). Researchers suggested that this is a good and safe therapy to treat these patients. Some background Overactive bladder (OAB) is a condition that is present in 23.3% of Americans. It consists of an uncontrollable need to...
Read MoreOveractive bladder Posts on Medivizor
Is mirabegron a safe and effective treatment for overactive bladder symptoms?
In a nutshell This paper investigated the effectiveness and safety of mirabegron (Myrbetriq) for the treatment of symptoms of overactive bladder (OAB). Mirabegron appeared to be safe and effective for the treatment of OAB symptoms. Some background OAB is characterized by symptoms such as experiencing incontinence (urine leakage), having a strong urge...
Read MoreCombining behavioral and drug therapies improves overactive bladder symptoms in men
In a nutshell This study investigated the effects of combining behavioral and drug therapies in male patients with overactive bladder (OAB). Researchers suggested that this combined therapy improves OAB symptoms. Some background OAB is a common condition. It can include frequent and urgent urination, incontinence (urine leak) and/or waking up at night...
Read MoreOnabotulinumtoxinA improves symptoms in patients with overactive bladder and urinary incontinence
In a nutshell This study investigated the effectiveness and safety of onabotulinumtoxinA (OBTA; Botox) in patients with overactive bladder and urinary incontinence. Researchers suggested that OBTA was associated with an improvement in urinary symptoms in these patients. Some background Overactive bladder (OAB) is a chronic disabling condition. The...
Read MoreMirabegron improves the quality of life of older patients with overactive bladder
In a nutshell This study investigated the quality of life outcomes in patients with overactive bladder (OAB) of 65 years of age or more. Researchers suggested that patients with OAB who received mirabegron (Myrbetriq) had improved quality of life. Some background OAB consists of an uncontrolled need or urge to urinate. Some people will leak urine when...
Read MoreThe effectiveness of mirabegron for overactive bladder in patients aged 65 and older
In a nutshell This study aimed to investigate the effectiveness of mirabegron in patients aged 65 years or older with overactive bladder (OAB) and urinary incontinence (UI). This study found that mirabegron improved the symptoms in these patients. Some background Overactive bladder (OAB) occurs when the bladder muscle is too active. Instead of staying...
Read MoreCan exercise intensity improve symptoms of overactive bladder in patients who are overweight?
In a nutshell This study compared the effects of high versus low-intensity exercise in overweight female patients with overactive bladder (OAB). The authors found that high-intensity exercise, but not low, decreased body fat and improved OAB symptoms for these patients. Some background OAB is a condition where a patient persistently...
Read MoreCan SBD treatment help improve symptoms of overactive bladder?
In a nutshell This study evaluated the outcomes of nerve inactivation treatment in women with overactive bladder. This study concluded that this treatment is effective for most patients. Some background Overactive bladder (OAB) is characterized by a sudden need or urge to urinate. One of the most common symptoms is urinary incontinence (UI), or...
Read MoreAre two drugs more beneficial than one for treating patients with overactive bladder?
In a nutshell This article reviewed several studies that compared the effectiveness of two drugs compared to one drug for treating symptoms of overactive bladder (OAB). The authors concluded that the combination of mirabegron (Myrbetriq) and solifenacin (Vesicare) was more effective than each drug alone and had similar side effects in these...
Read MoreComparing antimuscarinic treatment duration for women with overactive bladder syndrome
In a nutshell This study investigated the risk of retreatment after 3 or 6 months of antimuscarinic therapy for overactive bladder (OAB). This study found that prolonged antimuscarinic treatment does not increase the risk of retreatment for OAB. Some background Overactive bladder (OAB) occurs when the bladder muscle is too active....
Read MoreEvaluating current management of overactive bladder syndrome
In a nutshell This study reviewed the current management for overactive bladder in a real-world setting. The authors concluded that behavioral therapy and antimuscarinic drugs were the preferred therapies, corresponding to guideline recommendations. Some background Overactive bladder (OAB) occurs when the bladder muscle is too active....
Read MoreLooking for participants with benign prostatic hyperplasia and overactive bladder to test a new drug
In a nutshell This phase 3 trial is examining the effectiveness of vibegron in the treatment of overactive bladder symptoms (OAB) in patients with prostatic hyperplasia (BPH; enlarged prostatic gland). The main outcome of this trial will be a change in urgency episodes. This trial is being conducted in the US and Canada. The details A benign (not...
Read More
